Alkaline phosphatase (ALP) is an important biomarker that reflects osteoblast activity and bone growth. Accurately detecting ALP activity is of pivotal clinical significance for the diagnosis and differentiation of bone system diseases. In this work, an enhanced bipolar electrode electrochemiluminescence (BPE-ECL) biosensor based on enzyme catalysis and electrocatalysis was proposed for ultrasensitive detection of ALP in osteoblasts. Carbon nitride nanosheets (CNNS) were utilized as electrocatalysts to facilitate the electrochemical reaction of bipyridine ruthenium (Ru(bpy)32+) and tripropylamine (TPrA) in the reporting cell. Meanwhile, in the sensing cell, the target ALP catalyzed the conversion of p-aminophenyl phosphate monohydrate into p-aminophenol (p-AP). The p-AP was subsequently oxidized at the anode of the driving electrode, producing electrons and increasing the Faradaic current of BPE. The dual-signal amplification strategy, combining electrocatalysis and enzyme catalysis, resulted in a 10-fold enhancement of the ECL intensity of Ru(bpy)32+/TPrA. The BPE-ECL biosensor achieved ultrasensitive detection of ALP with a detection limit as low as 1.9×10−6 U/L, and was successfully applied to monitor ALP activity in osteoblast cells. Additionally, a portable smartphone imaging was developed for the visual detection of ALP. This research introduces an innovative BPE-ECL biosensor for the monitoring of ALP activity and point-of-care testing (POCT) in osteoblasts in clinical settings.
Read full abstract